不同评价方法在乳腺癌病人服药依从性中的应用被引量：6

Application of different evaluation methods in adherence of patients with breast cancer

下载PDF

导出

摘要 [目的]评价护士主导的个体化随访对术后行辅助内分泌治疗乳腺癌病人服药依从性的影响,比较3种评价方法对依从性测量结果的影响。[方法]抽取2012年1月—2012年12月在复旦大学附属肿瘤医院首次接受全身辅助内分泌药物治疗的乳腺癌病人,采用电脑产生的随机数字分为对照组和干预组,对照组采取内分泌常规护理,干预组在常规护理基础上实施6个月护士主导的个体化随访,采用Morisky服药依从性问卷(MAQ)、服药依从性视觉模拟评分(VAS)和药物占有比(MPR)评价两组病人在干预3个月和6个月时的服药依从率。[结果]干预3个月、6个月时干预组病人MPR均高于对照组(P<0.05),但两组MAQ、VAS值比较差异无统计学意义(P>0.05)。[结论]护士主导的个体化随访可以提高乳腺癌术后内分泌治疗病人的短期服药依从率。 To evaluate the influence of nurse led individual follow up on adherence of patients with breast cancer undergoing postoperative adj uvant endocrine therapy,then to compare the influence of 3 kinds of e-valuation methods on the adherence measurement results.Methods：The breast cancer patients were selected who first received adj uvant endocrine drugs for systemic treatment of patients from in January 2012 to December 2012 in affiliated tumor hospital in Fudan University,and they were divided into intervention group and control group by using computer generated random number.The patients in control group received routine nursing,pa-tients in intervention group took nurse led individual follow up for 6 months on the basis of conventional nursing.Morisky medication adherence questionnaire（MAQ）,medication adherence of visual analogue scale（VAS） and drug possession ratio（MPR）were used to evaluate the medication ad-herence rate of patients between both groups respectively in 3 months and 6 months after intervention.Results：After intervention for 3 months and 6 months,MPR of patients in intervention group was higher（P〈0.05）than that of control group,and there was no statistically significant difference（P〉0.05）in MAQ and VAS score between both groups.Conclusion：The nurse led individual follow up can improve short term treatment adherence rate of the postoperative endocrine therapy for patients with breast cancer.

作者朱叶卉裘佳佳胡雁吴密彬黄嘉玲陆箴琦

机构地区复旦大学护理学院复旦大学附属肿瘤医院

出处《护理研究（中旬版）》 2014年第7期2445-2448,共4页 Chinese Nursing Researsh

基金 2012年上海市卫生局科研项目编号:2012-96 复旦大学护理科研项目编号:FNSF201102

关键词乳腺癌内分泌治疗服药依从性护士主导的个体化随访 breast cancer endocrine therapy medication adherence nurse led individual follow up

分类号 R473.73 [医药卫生—护理学]

引文网络
相关文献

参考文献22

1Sabate E. WHO adherence meeting re- port[R]. Geneva : World Health Organ- ization, 2001 : 1.
2Haynes RB. Determinants of eompli- al.ce:The disease and the mechanics of treatment [ M]//Haynes RB, Sackett DL. Compliance in health care. Balti- more : Johns Hopkins University Press, 1979 :49 - 62.
3Rand CS. Measuring adherence with therapy for chronic diseases: Implications for the treatment of heterozygous familial hy- pereholesterolemia [J]. Am J Cardiol, 1993,72(10) :68D- 74D.
4Osterberg L,Blaschke T. Adherence to medieation[J]. N Engl J Med, 2005, 353(5) :487-497.
5Cox K,Wilson E. Follow -up for people with cancer: Nurse - led services and telephone interventions [J]. J Adv Nurs,2003,43(1) :51 - 61.
6Kimman ML, Dirksen CD, Voogd AC,et al. Nurse - led telephone follow - up and an educational group programme after breast cancer treatment: Results of a 2 X 2 randomised controlled trial [J]. Eur J Cancer,2011,47 (7) : 1027 - 1036.
7Kimman ML, Bloebaum MM, Dirksen CD, et al. Patient satisfaction with nurse- led telephone follow - up after curative treatment for breast cancer [J]. BMC Cancer, 2010,10 : 174.
8Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self- reported measure of medication adherence[J].Med Care, 1986,24 ( 1 ) : 67 - 74.
9Morisky DE, Ang A, Krousel - Wood M,et al. Predictive validity of a medi- cation adherence measure in an outpa- tient setting [ J ]. J Clin Hypertens (Greenwich), 2008,10(5) :348 - 354.
10张斯钰,白丽琼,谭红专,杨华林.Morisky服药依从性量表在肺结核患者中的应用[J].中国防痨杂志,2010,32(9):527-530. 被引量：107

二级参考文献8

1康华,蒋晓莲.肺结核病人服药依从性的研究进展[J].护理学杂志（综合版）,2004,19(15):76-78. 被引量：35
2谭卫国,杨应周,程锦泉,吴清芳,张玉华,罗育希,严薇荣,解瑞谦,钟球,王甦民.固定复合制剂治疗肺结核患者依从性分析[J].中国行为医学科学,2005,14(6):535-536. 被引量：7
3贺永鸿,成诗明,陈诚.固定剂量复合剂治疗肺结核患者依从性调查与分析[J].中国防痨杂志,2006,28(3):129-132. 被引量：12
4IUATLD/WHO. The promise and reality of fixed-dose combinations with rifampicin[J]. International Journal of Tuberculosis and Lung Disease, 1994, 75 :180--181.
5World Heath Organization Tuberculosis Program. Treatment of tuberculosis guidelines for national programs[S]. Geneva: WHO, 1993.
6Morisky DE, Ang A, Krousel-Wood M, Ward H. Predictive Validity of a Medication Adherence Measure for Hypertension Control[J]. Journal of Clinical Hypertension 2008, 10(5):348 -354.
7Hong Kong Chest Service/British Medical Research Council. Acceptability,compliance,and adverse reactions when isoniazid, ri fampin,and pyrazinamide are given as a combined formulation or separately during three-times-weekly antituberculosis chemotherapy[J]. Am Rev Respir Dis. 1989,140(6) : 1618-- 22.
8Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-report measure of medication adherence [J]. Med Care,1986,24:67- 74.